The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail


Zoetis Belgium S.A.VPA10387/035/001

Main Information

Trade NameGLETVAX 6
Active SubstancesE.coli k88ab antigen
E.coli k88ac antigen
E.coli k99 antigen
E.coli 987p antigen
Purified toxoids of Cl. perfringens
Dosage FormSuspension for injection
Licence HolderZoetis Belgium S.A.
Licence NumberVPA10387/035/001

Group Information

ATC CodeQI09AB08 escherichia + clostridium
Therapeutic ClassImmunological - Inactivated Vaccine


License statusAuthorised
Licence Issued29/08/2013
Legal StatusLM: Licensed Merchant as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back